CD79B and lymphoma: Upon binding of the monoclonal antibody to CD79b, a signaling component of the B cell receptor (4), pola is internalized to the major histocompatibility complex class II positive compartment and the linker is cleaved by proteases for subsequent delivery of MMAE into the CD79b-positive lymphoma cells.